 | | | | |
| |  | |  | | |
| |
| PRIME NEWS | |
|
 |
|
|
At the World Economic Forum in Davos, Switzerland, Gates Foundation Co-chair Mr Bill Gates announced a $750 million contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria
|
|
|
|
|
|
|
|
|
Ranbaxy Laboratories has announced that the consent decree with the US Food and Drug Administration (FDA) that was signed on December 20, 2011, has been filed with the United States District Court for the District of Maryland
|
|
|
|
|
|
|
| | | 
You are reading the most authoritative and influential source of information for lifesciences industry. BioSpectrum Asia is uniquely positioned as a specialized business-to-business information platform for life science articles in the Asia Pacific region. Updated every morning it brings to you comprehensive coverage and useful insights in the exciting areas of pharmaceuticals, biotech and medical devices.
| | | | |  | |  | | |
|
|
|
|
|
|
|
|
|
|
 |
|
 |
|
|
|
 |
PEOPLE |
 |
|
|
|
|
|
Dr Swati A Piramal to get Padma Shri
|
|
| Dr Swati A Piramal, director - Strategic Alliances & Communications, Piramal Healthcare, has been bestowed the Padma Shri award for her enormous contributions to the field of trade and industry |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
|
|
Researchers to pause on H5N1 research
|
|
| In an open letter to scientific researchers worldwide, a group of principal investigators from world renowned prestigious institutes have announced a moratorium on any research pertaining to avian influenza |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
Amerigen, VIWA sign MoU to develop generic medicines for China
|
|
| Amerigen Pharmaceuticals and VIWA Pharmaceutical jointly announced the signing of a memorandum of understanding setting out their intention to establish a joint venture to develop and register a range of branded generic medicines for sale in China |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
|
|
Ikaria product gets FDA orphan drug status
|
|
| The US Food and Drug Administration has granted orphan drug designation for the use of Ikaria's inhaled nitric oxide with the INOpulse DS drug delivery system to treat pulmonary arterial hypertension |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
|
|
Pain market remains area of high unmet need: report
|
|
| According to a new Espicom report despite a plethora of medications, the pain market remains an area of high unmet need as current therapies are often less than effective and/or have undesirable side effects |
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
